DK
Therapeutic Areas
Meitheal Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| XENLETA® (lefamulin) | Community-Acquired Bacterial Pneumonia | Approved |
| Contepo™ (fosfomycin) for injection | Anti-Infective | Approved |
| MAB-22 | Oncology | Preclinical |
| Filgrastim Biosimilar | Oncology (Neutropenia) | Preclinical |
| Pegfilgrastim Biosimilar | Oncology (Neutropenia) | Preclinical |
| Follitropin alpha (FSH) Biosimilar | Fertility | Preclinical |
| Insulin Aspart Biosimilar | Diabetes | Preclinical |
| Insulin Glargine Biosimilar | Diabetes | Preclinical |